• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与放射性碘难治性甲状腺乳头状癌的病理生理学

Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology.

机构信息

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center (EMRC), Dr. Shariati Hospital, Tehran, Iran.

出版信息

Trends Endocrinol Metab. 2020 Sep;31(9):627-630. doi: 10.1016/j.tem.2020.03.005. Epub 2020 Apr 6.

DOI:10.1016/j.tem.2020.03.005
PMID:32273149
Abstract

Gut microbiome (GM) might be associated with radioiodine (RAI)-refractory papillary thyroid carcinoma (PTC) through different mechanisms related to sodium/iodide (Na/I) symporter (NIS) regulation. However, whether thyroid carcinoma (TC), especially RAI-refractory PTC, causes dysbiosis, or vice versa, is still unknown. Further studies are needed to investigate the mechanism between GM and RAI-refractory PTC.

摘要

肠道微生物组(GM)可能通过与钠/碘(Na/I)转运体(NIS)调节相关的不同机制与放射性碘(RAI)难治性甲状腺乳头状癌(PTC)相关。然而,甲状腺癌(TC),特别是 RAI 难治性 PTC 是否会导致肠道菌群失调,或者反之亦然,目前尚不清楚。需要进一步研究来探讨 GM 和 RAI 难治性 PTC 之间的机制。

相似文献

1
Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology.肠道微生物群与放射性碘难治性甲状腺乳头状癌的病理生理学
Trends Endocrinol Metab. 2020 Sep;31(9):627-630. doi: 10.1016/j.tem.2020.03.005. Epub 2020 Apr 6.
2
An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na/I Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells.雌激素相关受体 γ 的反向激动剂 GSK5182 增强放射性碘难治性甲状腺乳头状癌细胞中的钠/碘同向转运体功能。
Cells. 2023 Feb 1;12(3):470. doi: 10.3390/cells12030470.
3
LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway.LARP7 在甲状腺乳头状癌中通过抑制 SHH 信号通路诱导 NIS 表达。
Mol Med Rep. 2018 Jun;17(6):7521-7528. doi: 10.3892/mmr.2018.8856. Epub 2018 Apr 5.
4
Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.锂作为分化型甲状腺癌放射性碘治疗的辅助剂:临床和体外研究。
Clin Endocrinol (Oxf). 2006 Jun;64(6):617-24. doi: 10.1111/j.1365-2265.2006.02515.x.
5
Effects of BRAF(V600E) mutation on Na(+)/I(-) symporter expression in papillary thyroid carcinoma.BRAF(V600E)突变对甲状腺乳头状癌中钠/碘同向转运体表达的影响。
J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):77-81. doi: 10.1007/s11596-016-1545-3. Epub 2016 Feb 3.
6
Post-translational Regulation of Radioactive Iodine Therapy Response in Papillary Thyroid Carcinoma.放射性碘治疗对甲状腺乳头状癌反应的翻译后调控。
J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx092.
7
The importance of sodium/iodide symporter (NIS) for thyroid cancer management.钠/碘同向转运体(NIS)在甲状腺癌治疗中的重要性。
Arq Bras Endocrinol Metabol. 2007 Jul;51(5):672-82. doi: 10.1590/s0004-27302007000500004.
8
Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma.甲状腺乳头状癌侵袭性变体中碘化钠同向转运体表达水平较低。
Int J Clin Oncol. 2014 Oct;19(5):800-4. doi: 10.1007/s10147-013-0620-z. Epub 2013 Oct 5.
9
Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer.盐酸青藤碱促进甲状腺乳头状癌细胞 TSHR 依赖性再分化。
Int J Mol Sci. 2022 Sep 14;23(18):10709. doi: 10.3390/ijms231810709.
10
Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.靶向新型钠碘转运体相互作用蛋白 ADP-核糖基化因子 4 和含缬氨酸蛋白增强放射性碘摄取。
Cancer Res. 2020 Jan 1;80(1):102-115. doi: 10.1158/0008-5472.CAN-19-1957. Epub 2019 Oct 31.

引用本文的文献

1
Bifidobacterium depletion promotes goiter via gut-thyroid axis: evidence from Mendelian randomization and experimental validation.双歧杆菌减少通过肠-甲状腺轴促进甲状腺肿:来自孟德尔随机化和实验验证的证据。
Front Microbiol. 2025 Jul 7;16:1621167. doi: 10.3389/fmicb.2025.1621167. eCollection 2025.
2
Integrated analysis of microbiome and host transcriptome revealed correlations between tissue microbiota and tumor progression in early-stage papillary thyroid carcinoma.微生物组与宿主转录组的综合分析揭示了早期乳头状甲状腺癌组织微生物群与肿瘤进展之间的相关性。
Front Cell Infect Microbiol. 2025 Jun 9;15:1571341. doi: 10.3389/fcimb.2025.1571341. eCollection 2025.
3
Correlations between serum cytokines and gut microbiota in patients with Graves' disease: A case-control study.
格雷夫斯病患者血清细胞因子与肠道微生物群的相关性:一项病例对照研究。
Medicine (Baltimore). 2025 Jun 20;104(25):e43000. doi: 10.1097/MD.0000000000043000.
4
Gut microbiome versus thyroid cancer: Association and clinical implications (Review).肠道微生物群与甲状腺癌:关联及临床意义(综述)
Oncol Lett. 2025 May 27;30(1):368. doi: 10.3892/ol.2025.15114. eCollection 2025 Jul.
5
Gut Microbiota Is Not Significantly Altered by Radioiodine Therapy.肠道微生物群不会因放射性碘治疗而发生显著改变。
Nutrients. 2025 Jan 22;17(3):395. doi: 10.3390/nu17030395.
6
Gut Microbiota Changes and Its Potential Relations with Thyroid Disorders: From Composition to Therapeutic Targets.肠道微生物群的变化及其与甲状腺疾病的潜在关系:从组成到治疗靶点
Int J Gen Med. 2024 Aug 26;17:3719-3731. doi: 10.2147/IJGM.S481183. eCollection 2024.
7
Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancer.探讨相互因果关系:肠道微生物组成和甲状腺癌的双向 Mendelian 随机化研究。
J Cancer Res Clin Oncol. 2024 Feb 3;150(2):75. doi: 10.1007/s00432-023-05535-y.
8
Causal analysis of the gut microbiota in differentiated thyroid carcinoma: a two-sample Mendelian randomization study.分化型甲状腺癌中肠道微生物群的因果分析:一项两样本孟德尔随机化研究
Front Genet. 2023 Dec 13;14:1299930. doi: 10.3389/fgene.2023.1299930. eCollection 2023.
9
Mendelian randomization suggests a causal relationship between gut dysbiosis and thyroid cancer.孟德尔随机化研究提示肠道菌群失调与甲状腺癌之间存在因果关系。
Front Cell Infect Microbiol. 2023 Dec 1;13:1298443. doi: 10.3389/fcimb.2023.1298443. eCollection 2023.
10
The relationship between thyroid and human-associated microbiota: A systematic review of reviews.甲状腺与人体相关微生物群的关系:系统评价综述。
Rev Endocr Metab Disord. 2024 Feb;25(1):215-237. doi: 10.1007/s11154-023-09839-9. Epub 2023 Oct 12.